CVS Health

CVS brought in roughly 402 billion dollars in revenue over the past year, up nearly 8 percent. That growth is coming from the insurance side finally making money again after two brutal years of blown medical cost estimates. Operating cash flow topped 10 billion dollars, which is the fuel for paying down debt and funding the dividend.

At about 133 billion dollars in market value against 402 billion in annual revenue, investors are paying very little for every dollar CVS collects. The dividend yields roughly 3.7 percent and eats up only around 43 percent of free cash flow, so it has room to survive a bad quarter. Getting more than 81 percent of Aetna's Medicare members into top rated plans unlocks bigger government bonus payments ahead.

CVS keeps just 0.72 percent of every dollar it takes in as profit. That is less than a penny per dollar, so a small miss on medical costs or pharmacy reimbursement rates can wipe out a quarter fast. Amazon and Walmart keep squeezing the retail pharmacy side, and there is almost no cushion for error.

Roughly 26 percent of CVS revenue depends on government health programs. The 2027 Medicare rate proposal landed at 2.48 percent, well under the 5.06 percent locked in for 2026, which directly squeezes what the insurance arm earns. Policy decisions made in Washington can move this stock hard in a single day, and that risk never really goes away.